Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Verified Perscriptions System ETCR -- Ignore unavailable to you. Want to Upgrade?

To: dkgross who wrote (374)	7/31/2003 11:08:51 AM
From: mtnres	Read Replies (1) \| Respond to of 397

ETCR's web site saying this is nearly a done deal....it's all up from here imo. Dear Investor, Pardon the cryptic nature of this communication, but we are prohibited from making any public statements regarding the Kentucky drug diversion monitoring pilot project to validate our provisionally-patented Verified Prescription SafeguardsTM system until a signed contract is in hand. Despite the notice on the Kentucky website (https://ky-purchases.com/servlet/KYECServlet?object=ViewAwards&action=show&main=yes) posted July 30, 2003. We have yet to receive a copy of the executed agreement for the project. You are, however, kind reader, completely free to read between the lines. One note of explanation regarding the entity awarded the contract, VPS Holding, LLC: Equity Technologies & Resources, Inc. and it’s subsidiary, Verified Prescription Safeguards, Inc., assigned all intellectual property rights to our VeriscripTM prescription drug monitoring system for controlled substances to VPS Holding, LLC, a Kentucky limited liability company of which I am president and CEO. In anticipation of development and funding for the Verified Prescription SafeguardsTM system, VPS Holding, LLC, entered into an Agreement with Envoii Healthcare, LLC, and subsequently with Envoii Pharmacy, LLC. In the absence of any contracts or funding for the project, this was the only viable alternative available. Since Envoii has been pursuing similar technology in the healthcare industry, it was practical and prudent to partner with the Envoii Pharmacy technology. The manner in which the funding and technology development issues have been structured will beneficially protect both the creditors and the stockholders of Equity Technologies & Resources, Inc., and Verified Prescription Safeguards, Inc. This has been a long road, and many more miles lie ahead until we reach our goal. But a significant step has occurred. We thank each and every one of our loyal and supportive shareholders who have kept the faith, stayed the course, and — we firmly believe — will be rewarded. Very best regards, Best wishes, James Kemper Millard President & Chief Executive Officer Equity Technologies & Resources, Inc. 325 West Main Street, Suite 240 Post Office Box 12012 Lexington, Kentucky 40579 VOX: 859.268.4446 eFAX: 419.821.3646 This communication may contain forward-looking statements. The Company expressly disclaims any intent or obligation to update any forward-looking statements. Verified Prescription Safeguards, VeriScrip, and VPS are trademarks of Verified Prescription Safeguards, Inc., a wholly owned subsidiary of Equity Technologies & Resources, Inc. Envoii is a trademark of Envoii, Inc.